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an Adverse Prognosis in Nonischemic Cardiomyopathy
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Objectives We examined whether the presence and extent of late gadolinium enhancement (LGE) by cardiovascular mag-
netic resonance (CMR) predict adverse outcomes in nonischemic cardiomyopathy (NICM) patients.
Background Morbidity and mortality is high in NICM patients. However, the clinical course of an individual patient is unpre-
dictable and current risk stratification approaches are limited. Cardiovascular magnetic resonance detects myo-
cardial fibrosis, which appears as LGE after contrast administration and may convey prognostic importance.
Methods In a prospective cohort study, 65 NICM patients with left ventricular (LV) ejection fraction 35% underwent CMR
before placement of an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac
death. The CMR images were analyzed for the presence and extent of LGE and for LV function, volumes, and
mass. Patients were followed for an index composite end point of 3 cardiac events: hospitalization for heart fail-
ure, appropriate ICD firing, and cardiac death.
Results A total of 42% (n  27) of patients had CMR LGE, averaging 10  13% of LV mass. During a 17-month median
follow-up, 44% (n  12) of patients with LGE had an index composite outcome event versus only 8% (n  3) of
those without LGE (p  0.001 for Kaplan-Meier survival curves). After adjustment for LV volume index and func-
tional class, patients with LGE had an 8-fold higher risk of experiencing the primary outcome (hazard ratio 8.2,
95% confidence interval 2.2 to 30.9; p  0.002).
Conclusions A CMR LGE in NICM patients strongly predicts adverse cardiac outcomes. The CMR LGE may represent the end-
organ consequences of sustained adrenergic activation and adverse LV remodeling, and its identification may
significantly improve risk stratification strategies in this high risk population. (Imaging Techniques for Identifying
Factors of Sudden Cardiac Death Risk; NCT00181233) (J Am Coll Cardiol 2008;51:2414–21) © 2008 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.018f
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natients with nonischemic cardiomyopathy (NICM) com-
rise one-third of the heart failure (HF) population and are
t risk for significant morbidity and mortality (1,2). Non-
schemic cardiomyopathy is the most common indication
or heart transplantation. Ten-year survival is below 60%
3), with deaths often preceded by frequent hospitalizations
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ational Heart, Lung, and Blood Institute, National Institutes of Health (K23
L04444 to Dr. Wu). Drs. Wu and Lima receive research grant support from GE
ealthcare Technologies.h
Manuscript received November 27, 2007; revised manuscript received March 13,
008, accepted March 17, 2008.or HF exacerbations (4). Forty percent of deaths are sudden
ardiac death (SCD), and placement of an implantable
ardioverter-defibrillator (ICD) for primary prevention re-
uces arrhythmic deaths in NICM patients with left ven-
ricular (LV) ejection fraction (LVEF) 35% (5–7). How-
ver, risk stratification remains challenging, particularly in
he individual patient in whom the clinical course frequently
orrelates poorly with LVEF. Better risk-stratification tools
ight allow earlier intervention in high-risk patients, im-
roving both quality of life and survival.
In patients with NICM, myocardial fibrosis has been
dentified pathologically (8). Macroscopic regions of fibrosis
ave also been visualized by cardiovascular magnetic reso-
ance (CMR), appearing as areas of late gadolinium en-
ancement (LGE) (9–11). Increasing amounts of fibrosis
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June 24, 2008:2414–21 CMR and Prognosis in Nonischemic Cardiomyopathyotentially result in increased LV stiffness and reduced LV
ompliance, thereby progressively impairing both diastolic
nd systolic function, reducing cardiac output (8). Myocar-
ial fibrosis may also form a substrate for lethal re-entrant
entricular arrhythmias (12,13). We therefore hypothesized
hat the presence and extent of CMR LGE are associated
ith a higher risk of adverse cardiac outcomes in patients
ith NICM and LVEF 35%.
ethods
atients. We conducted this pre-specified single-center
rospective cohort study between April 2004 and April
007 as part of a larger prospective registry of both non-
schemic and ischemic cardiomyopathy patients undergoing
CD implantation for primary prevention of SCD. The
resent study included consecutive nonselected patients
ith NICM and LVEF 35% by a clinically indicated
on-CMR study (echocardiography or nuclear), referred for
CD by their treating cardiologist. All patients had coronary
ngiography and were classified as nonischemic if they had
o history of myocardial infarction or revascularization and
o evidence of coronary artery stenoses 50% of 2 or more
picardial vessels or left main or proximal left anterior
escending coronary artery stenosis 50% (14). We ex-
luded patients with prior arrhythmic indications for ICD
lacement (such as a history of syncope, cardiac arrest, or
entricular arrhythmias); New York Heart Association
NYHA) functional class IV; and acute myocarditis, con-
enital heart disease, hypertrophic cardiomyopathy, or in-
ltrative heart disease. Renal insufficiency with creatinine
learance 30 ml/min was added as an exclusion in July
006. The study protocol was approved by the Johns
opkins Hospital Institutional Review Board. All patients
ave written informed consent.
RI protocol. Before ICD implantation, patients under-
ent CMR using a 1.5-T scanner (Signa CV/i, GE
ealthcare Technologies, Waukesha, WI; or Siemens Avanto,
rlangen, Germany). Cine images were acquired with a
teady-state free-precession pulse sequence (TR 2.5 to 3.8,
E 1.1 to 1.6, average in-plane resolution 1.5  2.4 mm,
ip angle 45° to 60°, temporal resolution 40 to 45 ms) in
ong-axis planes and contiguous 8-mm short-axis slices
rom the mitral annulus to the apex. Fifteen to thirty
inutes after intravenous administration of 0.2 mmol/kg
adodiamide (Omniscan, GE Healthcare Technologies),
elayed contrast-enhanced images were acquired using
nversion-recovery fast gradient-echo pulse sequences
15,16) in the same short-axis locations as the cine images.
o exclude artifact, short-axis imaging was repeated in 2
ifferent phase-encoding directions and cross-sectional long
xis views were also acquired. Imaging parameters were: TR
.4 to 8.3 ms, TE 1.3 to 3.9 ms, average in-plane spatial
esolution 1.4 to 1.5 2.2 to 2.4 mm, 8-mm slice thickness,
-mm gap, TI 175 to 300 ms (adjusted as needed in the
elayed-enhancement image acquisitions to optimally null che signal of normal myocar-
ium), 1 to 2 R-R imaging, and
ip angle 20° to 25°.
ata analysis. Analysis of the
MR Digital Imaging and
ommunications in Medicine
DICOM) images was performed
sing CINEtool software (GE
ealthcare Technologies). Left
entricular ejection fraction, vol-
mes, and mass were quantified
rom the cine images by standard
ethods. Left ventricular volumes
nd mass were normalized to
ody surface area. Two observers
linded to the clinical outcome
ndependently determined the di-
hotomous presence or absence of
GE by reviewing all short- and
ong-axis contrast-enhanced im-
ges; regions of elevated signal in-
ensity had to be confirmed in 2
patial orientations.
If CMR LGE was present, the quantitative extent of
yperenhancement was defined as regions with abnormally
ncreased signal intensity greater than peak remote (17). For
ach short-axis cross section, after the endocardial and
picardial borders were traced, a region of interest averaging
0 mm2 was defined within the normal remote myocardium
n an area with uniform myocardial suppression free of
rtifacts. The peak signal intensity (SI) within the remote
egion of interest was then determined. Total myocardial
GE was defined as abnormal myocardium with SI above
eak remote SI and expressed as a percent of total LV mass
nd as a total volume.
Intraobserver reproducibility of the extent of LGE using
he peak remote threshold was measured. In addition,
omparison was made with the extent of the LGE region
uantified using a threshold of 2 standard deviations
bove mean remote SI (11).
linical follow-up. Patients were followed at 3- to
-month intervals after ICD placement via clinic visits or
hone calls. The primary outcome of the study was the
ndex combined end point of cardiac death (both sudden
nd nonsudden), appropriate ICD firing, and hospitaliza-
ion for decompensated HF requiring intravenous diuretics
ith or without inotropes. No patient was lost to follow-up.
vents were adjudicated by an independent committee
linded to the CMR results. Deaths were classified accord-
ng to the modified Hinkle-Thaler system (18). Appropriate
CD firing was defined as a shock for sustained ventricular
achycardia above the programmed rate cutoff of the ICD
generally 180 beats/min) or ventricular fibrillation.
tatistical analysis. Continuous variables are expressed
s mean  SD. The Wilcoxon rank sum test was used to
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
HF  heart failure
ICD  implantable
cardioverter-defibrillator
LGE  late gadolinium
enhancement
LV  left ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
NICM  nonischemic
cardiomyopathy
NYHA  New York Heart
Association
SCD  sudden cardiac
death
SI  signal intensityompare continuous baseline and CMR characteristics of
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CMR and Prognosis in Nonischemic Cardiomyopathy June 24, 2008:2414–21he patients grouped by the dichotomous presence or
bsence of CMR LGE. The Fisher exact test was used for
ategoric variables. Kaplan-Meier curves and the Wil-
oxon test of Breslow were used to compare univariate
urvivor functions (time to index composite event). Cox
roportional-hazards models were developed. We in-
luded as potential covariates age, gender, baseline
YHA functional class, and LVEF, mass, and volume
ndexes, which are known from earlier research to affect
rognosis in NICM (19). No other additional baseline
haracteristics were found to influence the relationship
etween CMR LGE and outcome. Because there was
trong collinearity (correlation coefficient 0.6) between
Baseline Demographic, Clinical, and MagneticRe onance I aging Characteristics of the Patie
Table 1 Baseline Demographic, Clinical, andResonance Imaging Characteristics
Variable LGE Absent by CM
Age, yrs 55 1
Male gender, n (%) 19 (50)
Caucasian, n (%) 19 (50)
Duration of cardiomyopathy
diagnosis, yrs
4.0 4
Entry EF (non-MRI method), % 21 9
Single-vessel CAD 50% (non-left
main or proximal LAD vessels)
2 (5)
NYHA functional class
I 7 (18)
II 16 (42)
III 15 (39)
Medication use, n (%)
ACEI or ARB 33 (87)
Beta-blocker 36 (95)
Diuretic 22 (65)
Spironolactone 11 (29)
Digoxin 15 (39)
Antiarrhythmics (amiodarone) 2 (5)
Lipid-lowering 16 (42)
Received biventricular ICD, n (%) 15 (41)
CMR measurements
LVEF, % 26 9
LVEDV index, ml/m2
All patients 126 4
Female 120 3
Male 132 4
LVESV index, ml/m2
All patients 96 4
Female 89 3
Male 104 5
LV mass, g/m2
All patients 78 2
Female 73 1
Male 83 2
Extent of LGE, mean SD —
Median extent
Interquartile range
Total volume, ml
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin
magnetic resonance; EF ejection fraction; ICD implantable cardiov
gadolinium enhancement; LV left ventricular; LVEDV left ventricular end-d
ventricular end-systolic volume; MRI  magnetic resonance imaging; NYHA VEF, volumes, and mass, only left ventricular end-
iastolic volume (LVEDV) was included in the models.
orward stepwise regression (p  0.10 for entry; p 
.05 for removal) was used to arrive at a parsimonious
odel (model 1). Given the well established prognostic
mportance of LVEDV, this was added to the parsimo-
ious model for the final analysis of all patients (model
). Follow-up duration was measured from the CMR
tudy date. Bland-Altman repeatability analysis was used
o compare quantification of the LGE region using the
hresholds of peak remote versus 2 SD above mean
emote as well as intraobserver variability. A 2-tailed p
alue of 0.05 defined statistical significance.
netic
e Patients
38) LGE Present by CMR (n  27) p Value
56 9 0.99
23 (85) 0.003
15 (58) 0.14
4.1 4.4 0.74
19 6 0.47
3 (11) 0.38
0.52
3 (11)
15 (56)
9 (33)
25 (92) 0.46
24 (89) 0.64
19 (73) 0.38
8 (30) 0.95
5 (19) 0.07
4 (15) 0.19
16 (59) 0.17
8 (30) 0.37
22 10 0.20
149 64 0.10
137 96
151 67
120 66 0.08
109 44
122 69
90 43 0.16
71 21
93 45
10 13% of LV mass —
5%
3%–16%
17 21
tor blocker; CAD  coronary artery disease; CMR  cardiovascular
fibrillator; LAD left anterior descending coronary artery; LGE latents
Mag
of th
R (n 
2
.1
3
7
9
1
6
0
4
7
9
recep
erter-deiastolic volume; LVEF left ventricular ejection fraction; LVESV left
New York Heart Association.
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June 24, 2008:2414–21 CMR and Prognosis in Nonischemic Cardiomyopathyesults
aseline characteristics. We enrolled 65 patients whose
aseline clinical characteristics are presented in Table 1.
edian follow-up for the survivors was 17 months.
wenty-seven patients (42%) had CMR LGE with the
ollowing regional patterns: septal midwall (Fig. 1A) (n 
), subendocardial extending to epicardial surface (Fig. 1B)
n  7), and patchy foci (Fig. 1C) (n  12) often including
he RV-LV septal insertion points.
Patients with and without CMR LGE had similar baseline
haracteristics, including duration of cardiomyopathy diagno-
is, entry NYHA functional class, medication usage (both at
aseline and at follow-up), and biventricular ICD usage,
lthough LGE was more frequent in men. Only 5 of the 65
atients had single-vessel coronary artery disease (CAD; not
nvolving the left main or proximal left anterior descending
oronary artery). This is consistent with cardiomyopathy “out
f proportion” to CAD extent, and none of the 5 had evidence
f LGE in that specific coronary distribution. The LVEF
rended lower and LV volume and mass indexes were higher in
hose patients with LGE compared with those without LGE.
Serum sodium and creatinine values were identical in
oth groups. Pro–B-type natriuretic protein (BNP) values
pg/ml) were obtained in a subset of patients (n  42) and
ere significantly different between the 2 groups: 1,041 
,448 for patients without LGE (n  24) versus 4,497 
,519 for those with LGE (n  18); p  0.002.
A
C1 C
Figure 1 CMR Late Gadolinium Enhancement Patterns Observe
(A) Predominantly midwall enhancement involving the septal, anterior, and anterol
dial enhancement). (C) Patterns of patchy foci not following an epicardial coronary
is basal septal enhancement. Arrows indicate regions of late gadolinium enhanceeproducibility of CMR LGE. For the dichotomous
resence or absence of LGE, there was complete intraob-
erver agreement. There was only 1 case of interobserver
isagreement, which was resolved by consensus with a third
ndependent observer. For quantification of the LGE re-
ion, intraobserver variability using the peak remote thresh-
ld was extremely low, with mean difference (bias) of 0.1 ml
95% confidence interval [CI] 0.3 to 0.5 ml, limits of
greement 1.9 to 2.1 ml). Low interobserver variability of
his method has previously been shown (17). Compared
ith the 2 SD above mean remote SI, the current
ethodology for quantifying LGE resulted in slightly larger
egions (17.4 20.8 ml vs. 16.6 21.2 ml, bias 0.8, 95% CI
.3 to 1.3, limits of agreement 1.6 to 3.2).
MR LGE and clinical outcome. The presence of CMR
GE was associated with an increased risk of sustaining an
ndex composite cardiac event over time. Kaplan-Meier
urves (Fig. 2) for the index composite end point showed a
ignificant difference between patients with and without
MR LGE (Wilcoxon-Breslow: p  0.001). Twelve pa-
ients (44%) with LGE had an index composite event (8
ith an HF hospitalization and 4 with an appropriate ICD
ring), compared with 3 patients (8%) without LGE, all of
hom had an ICD firing (Table 2). The median time to an
ndex event was 10.2 months. Among the 12 patients with
GE and index events, additional subsequent events were
ommon (Table 2): 3 patients died within 2 months of the
he Study Group
walls. (B) Apical-lateral near-transmural enhancement (subendocardial to epicar-
sion territory. (C1) There is a focus of midlateral wall enhancement. (C2) ThereB
2
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CMR and Prognosis in Nonischemic Cardiomyopathy June 24, 2008:2414–21ndex event (2 patients with an initial HF hospitalization
ubsequently died of LV pump failure and 1 patient with an
nitial ICD firing died of SCD); 2 patients had multiple
ppropriate ICD firings on separate dates; and 3 patients
ith an index HF hospitalization had subsequent HF
ospitalizations. There were no deaths or HF hospitaliza-
ions among patients without CMR LGE.
By univariate analysis (Table 3), the presence of CMR
GE was strongly associated with cardiac events (hazard
atio [HR] 7.1, 95% CI 2.0 to 25.3; p  0.002). This
ssociation was unchanged in multivariate analysis: CMR
GE had a hazard ratio of 8.2 (95% CI 2.2 to 30.9; p 
.002) for an index composite event after adjustment for HF
lass and LVEDV index. When the 5 patients with CAD
ere excluded, both univariate and multivariate results
ontinued to show significant association between CMR
GE and adverse outcome (Table 3). Because LVEF, LV
imensions, and LV volume and mass indexes were corre-
ated, we used only the LVEDV index in Cox proportional
azard models; the results were unchanged when LVEF was
ubstituted for the LVEDV index or when all CMR volume
nd mass indexes were used and when CHF class was
odeled as a categoric rather than an ordinal variable.
imilarly, the addition of serum sodium and creatinine
alues was not predictive of outcome and did not change the
ultivariate results. Including whether or not a biventricular
acemaker was placed also did not change the multivariate
esults, and neither did medication usage. When the end
oint was limited to cardiac death and appropriate ICD
ring, thus excluding HF hospitalization, LGE continued
o predict a significantly worse outcome by Kaplan-Meier
nalysis (Wilcoxon-Breslow: p  0.03): 22% (n  6) of
atients with LGE reached this secondary end point versus
nly 8% (n  3) without LGE.
Among patients with LGE, even small amounts of LGE
Figure 2 Kaplan-Meier Event-Free Survival Curve for
the Occurrence of an Index Composite Event
Patients are grouped by presence or absence of cardiovascular magnetic reso-
nance late gadolinium enhancement. Wilcoxon-Breslow: p  0.001 for the 2
survival curves.ere associated with a significant risk of an index adverse
eutcome: for the 13 patients whose % LV LGE mass
easured below the median, the multivariate adjusted HR
as 6.7 (95% CI 1.4 to 31.8; p  0.016), compared with an
R of 11.9 (95% CI 2.1 to 66.8; p  0.005) for those with
alues above the median. The rates of index adverse out-
ome occurrence were similar among the 3 qualitative
egmental patterns of LGE: 38% of patients with a midwall
attern, 43% of those with a transmural pattern, and 50% of
hose with patchy LGE had an index outcome event.
xcluding those with the transmural pattern did not signif-
cantly change the univariate and multivariate HRs for LGE.
iscussion
his study found that among patients with NICM, the
resence of LGE on CMR, irrespective of extent or
egmental pattern, is independently associated with an
dverse cardiac prognosis. After controlling for LV volume,
ass, or ejection fraction as well as NYHA functional class,
he adjusted HR for patients with CMR LGE was 8.2 (95%
I 2.2 to 30.9; p  0.002) for an index composite cardiac
vent compared with those without LGE.
The CMR LGE patterns seen in the present patients are
onsistent with those reported in earlier pathologic studies
f NICM (9). Earlier studies examining myocardial tissue
amples obtained at the time of autopsy or cardiac trans-
lantation have shown a pattern of increasing fibrosis from
he epicardium to endocardium with both septal and LV
ree wall involvement (20–22). Segmental and replacement
brosis (23) have been described in as many as 57% of
atients (21), and grossly visible scars have been noted in
3% (24). The frequency and pattern of CMR LGE in the
resent patients are consistent with those findings. The
xact pathophysiology underlying the CMR abnormalities is
ncertain, because NICM is the final common pathway for
resumably multiple etiologies. In all likelihood, focal CMR
GE in the present patient population is a nonspecific
easure of replacement and segmental fibrosis. These types
umber of Index and Cumulative Eventsroup d by Pr sence or Absence of CMR LGE
Table 2 Number of Index and Cumulative EventsGrouped by Presence or Absence of CMR LGE
Variable
LGE Absent by
CMR
(n  38)
LGE Present by
CMR
(n  27)
Number of patients who experienced
an index composite outcome*
3 (8%) 12 (44%)
HF hospitalization 0 8
Appropriate ICD firing 3 4
Cardiac death 0 0
Cumulative number of events over the
follow-up period
3 25
HF hospitalization 0 13
Appropriate ICD firing 3 9
Cardiac death 0 3
The primary statistical analysis in the text was performed using the number of patients
xperiencing an index composite outcome and time to the index event. The cumulative number of
vents was not used in any statistical analysis.
HF  heart failure; other abbreviations as in Table 1.
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June 24, 2008:2414–21 CMR and Prognosis in Nonischemic Cardiomyopathyf myocardial injury in NICM likely result from chronic
ustained adrenergic activation that eventually leads to
rogressive myocyte dysfunction, apoptosis, and fibroblast
yperplasia (8). In addition, the increased wall stress caused
y progressive LV remodeling can result in focal myocyte
ecrosis due to microvascular ischemia from augmentation
f metabolic demands as well as reduced capillary density
rom excessive fibrosis (8,25). Current CMR techniques are
ess likely to detect diffuse microscopic fibrosis.
The finding of a strong association between poor cardiac
rognosis and CMR LGE supports that of a more narrowly
ocused report by Assomull et al. (11), who specifically
tudied the significance of the CMR LGE pattern of
idwall fibrosis in 101 patients with symptomatic NICM.
hat study found focal midwall fibrosis sparing the endo-
ardium in 35% of patients, with an HR of 3.1 (95% CI 1.1
o 8.5; p  0.03) for the combined outcome of all-cause
ortality and hospitalization for any type of cardiovascular
vent, after adjustment for age, LV function, and chamber
olumes measured by CMR. Our results suggest that
dverse cardiac prognosis is specifically associated with the
resence of LGE, regardless of segmental pattern. Com-
ared with the study by Assomull et al. (11), which was
erformed at a regional HF referral center, the present
ohort may be more generalizable to the ICD-eligible
ICM population at large; our patients were older, more
thnically diverse, received cardiac care from general cardio-
ogists, and had uniformly severe LV dysfunction. In addi-
ion, patients were classified as nonischemic by coronary
ngiographic findings, which is consistent with current
linical practice and an accurate definition of cardiomyop-
thy etiology for clinical research purposes (14). In so doing,
e examined the significance of all CMR patterns in this
roup. Our study design was also prospective and concur-
ent, that is, assessment of CMR LGE preceded clinical
ox Proportional Hazards Analysis for the Time to Occurrence of an
Table 3 Cox Proportional Hazards Analysis for the Time to Occ
Variable
Univariate Ana
Unadjusted HR
(95% CI)
Age (5-yr increments) 1.1 (0.9–1.5)
Gender 1.8 (0.5–6.2)
NYHA functional class 2.0 (0.8–4.5)
CMR LVEDV index (ml/m2) (per 10-ml/m2 increments) 1.1 (1.0–1.2)
Presence of CMR LGE (vs. absence) 7.1 (2.0–25.4)
Excluding P
Age (5-yr increments) 1.2 (0.9–1.6)
Gender 1.9 (0.5–6.8)
NYHA functional class 1.8 (0.8–4.4)
CMR LVEDV index (ml/m2) (per 10-ml/m2 increments) 1.1 (1.0–1.2)
Presence of CMR LGE (vs. absence) 8.9 (2.4–32.2)
For model 1 (parsimonious model), forward stepwise regression (p  0.10 for entry; p  0.05 for
ndex, and LGE fibrosis were all entered into the multivariate model.
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.ollow-up and outcome events were pre-defined at study onset. pAlthough we report significantly higher rates of adverse
ardiac outcomes in NICM patients with CMR LGE, the
bsence of LGE did not assure freedom from malignant
entricular arrhythmias: 3 patients (9%) without LGE had
n appropriate index ICD firing, compared with 4 patients
15%) with LGE. Significant arrhythmic risk in NICM
atients without LGE is not surprising, because ventricular
rrhythmias can be caused not only by fibrosis, with focal
e-entry in regions of tissue heterogeneity (13,26–28), but
lso in the absence of fibrosis, by bundle branch or interfa-
icular re-entry and by exaggerated spatial dispersion of
lectrophysiological properties and abnormal impulse initi-
tion (27,28).
In addition, although the presence of LGE does predict
CD firings or cardiac death alone (p  0.03 by Kaplan-
eier analysis), HF hospitalization was a prominent deter-
inant of the overall outcome. Although we did not study
he mechanism by which increased CMR LGE leads to
orse overall or, specifically, HF prognosis, the dose-
esponse relationship between the extent of LGE and
utcome supports the hypothesis that the CMR findings
eflect the transition from compensated to decompensated
tate which results from long-term stressors such as sus-
ained adrenergic activation and/or the mechanical disad-
antages caused by LV remodeling. The presence of even
mall amounts of macroscopic scar may indicate maladap-
ion at the cellular level with myocyte apoptosis and necro-
is, thus heralding the start of a progressively more symp-
omatic stage of the disease process. This is further
uggested by the limited BNP data which indicate higher
evels consistent with increased LV wall stress and interven-
ricular pressures in patients with CMR LGE. Further
nvestigation into the pathophysiology is required.
tudy limitations. The present study has inherent limita-
ions given its relatively small cohort size and follow-up
x Composite Cardiac Event
ce of an Index Composite Cardiac Event
Multivariate Analysis
Model 1* Model 2†
alue
Adjusted HR
(95% CI) p Value
Adjusted HR
(95% CI) p Value
8 — — — —
9 — — — —
2 2.7 (1.0–7.2) 0.04 2.6 (1.0–7.0) 0.05
8 — — 1.0 (0.9–1.1) 0.70
02 8.6 (2.4–31.6) 0.001 8.2 (2.2–30.9) 0.002
With CAD
7 — — — —
3 — — — —
7 — — 2.1 (0.8–5.5) 0.15
4 — — 1.0 (0.9–1.1) 0.9
01 8.9 (2.4–32.2) 0.001 9.2 (2.4–35.1) 0.001
l) was used to arrive at a parsimonious model. †For model 2, NYHA functional class, CMR LVEDVInde
urren
lysis
p V
0.2
0.3
0.1
0.0
0.0
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ize is likely too small for definitive conclusions about
ifferential risk. Robust conclusions regarding the ability of
GE to predict each separate component of the combined
nd point are also limited. Patients underwent CMR at
nrollment only, so the implications of temporal progression
r regression of LGE or changes in regional pattern are
nknown. Our CMR protocol used the inversion recovery
echnique, which is sensitive for replacement and segmental
brosis but relatively insensitive for diffuse microscopic
nterstitial fibrosis. The present study included only patients
ith LVEF 35%, although the study by Assomull et al.
11) suggests that CMR LGE may be prognostically im-
ortant for NICM patients with moderate LV systolic
ysfunction as well.
onclusions
he presence of CMR LGE identifies a subset of NICM
atients with an 8-fold higher risk of an index composite
utcome of HF hospitalization, appropriate ICD firings,
nd cardiac death compared with patients without LGE.
he CMR scanning and interpretation are relatively
traightforward and can be performed at many hospitals that
outinely provide care for patients with heart disease. Future
esearch will be needed to determine whether therapy
uided by CMR findings can lower morbidity and mortality
or patients with nonischemic cardiomyopathy and LGE,
uch as with intensive heart failure therapies and/or earlier
onsideration of cardiac transplantation or left ventricular
ssist device placement. In addition, extrapolation to patients
ith milder LV systolic dysfunction may better identify those
atients at high clinical risk who are currently not recog-
ized as such by global LV function and volumes alone.
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